Rationale for Using Albumin with Furosemide

Evidence-Based Indications

The International Collaboration for Transfusion Medicine Guidelines explicitly states that intravenous albumin is not suggested for first-line volume replacement or to increase serum albumin levels in critically ill adult patients (conditional recommendation, moderate certainty of evidence) 2, 3, 4
The American Association for the Study of Liver Diseases recommends albumin (8 g per liter of ascitic fluid removed) together with furosemide after paracentesis >5 liters to prevent post-paracentesis circulatory dysfunction (Level A1 recommendation) 1
The European Society of Pediatric Nephrology suggests considering furosemide at the end of each albumin infusion in the absence of marked hypovolemia or hyponatremia 1

Albumin carries significant risks, including fluid overload and pulmonary edema, especially with compromised cardiac/pulmonary function 5
Albumin can cause hypotension and tachycardia despite intended volume expansion 5
Albumin can lead to hemodilution potentially requiring RBC transfusion 5
Albumin can cause anaphylactic/allergic reactions 5
The use of albumin is associated with high cost (~$130/25g) without proven mortality benefit 2, 3

The American College of Chest Physicians confirms that the combination of albumin and furosemide does not improve mortality, ventilator-free days, or meaningful clinical outcomes in critically ill patients 1
Administer furosemide within 2 hours following albumin infusion 1
Infuse furosemide over 5-30 minutes to minimize ototoxicity risk 1
Do not exceed 1 week of high-dose furosemide due to ototoxicity 1
Closely monitor fluid status, electrolytes, blood pressure, and renal function 1